Cyclo Therapeutics, Inc. SEC Filings

Filed On	Filing
07 Apr 2025	FORM 15-12G
26 Mar 2025	25-NSE
26 Mar 2025	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
24 Mar 2025	8-K: Submission of Matters to a Vote of Security Holders
06 Mar 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
03 Mar 2025	Form 4: Conkling William, Director Received 27,654 shares as a grant or award
03 Mar 2025	Form 4: Wong Vivien, Director Received 25,140 shares as a grant or award
03 Mar 2025	Form 4: Cross Shawn, Director Received 28,597 shares as a grant or award
03 Mar 2025	Form 4: Toig Randall M., Director Received 33,311 shares as a grant or award
03 Mar 2025	Form 4: Strattan Ce Rick, Director Received 30,169 shares as a grant or award
03 Mar 2025	Form 4: Ostronic Francis Patrick, Director Received 70,329 shares as a grant or award
03 Mar 2025	Form 4: Sieger Markus, Director Received 58,138 shares as a grant or award
28 Feb 2025	Form 4: Shanahan William S, Director Received 25,140 shares as a grant or award
14 Feb 2025	UPLOAD
04 Feb 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
13 Jan 2025	Form 4: Rafael Holdings, Inc., 10% owner Received 3,968,254 shares by conversion ($2.5M)
13 Jan 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
03 Jan 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
23 Dec 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
18 Dec 2024	CORRESP

Comments